Lorraine Pelosof, MD, PhD, assistant professor of Hematology and Oncology, UT Southwestern Medical Center, on the increasing proportion of non-smokers developing non-small cell lung cancer (NSCLC).
Lorraine Pelosof, MD, PhD, assistant professor of Hematology and Oncology, UT Southwestern Medical Center, on the increasing proportion of non-smokers developing non-small cell lung cancer (NSCLC). Pelosof says 10-to-15% of NSCLC patients are non-smokers, though that statistic has been debated over the years. She adds that the ration of non-smokers developing small cell lung cancer has remained constant.
Amivantamab/Lazertinib Shows OS and PFS Benefits in EGFR-Mutated NSCLC
April 21st 2025During a live event, Xiuning Le, MD, PhD, discussed updated intracranial efficacy, overall survival, and safety of amivantamab plus lazertinib in patients with EGFR-mutated non–small cell lung cancer.
Read More